Curanex Pharmaceuticals Inc (CURX) vs Lexaria Bioscience Corp. (LEXX)

Curanex Pharmaceuticals Inc and Lexaria Bioscience Corp. are both Biotechnology companies. Curanex Pharmaceuticals Inc and Lexaria Bioscience Corp. are of similar size ($7.1M and $7.0M). Across the 9 metrics below, Lexaria Bioscience Corp. leads on 7 and Curanex Pharmaceuticals Inc on 2.

Valuation

Metric CURX LEXX Biotechnology median
P/E n/m n/m 7.88
P/S n/m 10.01 11.47
P/B 1.40 1.25 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m 3.66 10.73
Earnings yield (164.56%) (155.41%) (28.84%)
Free cash flow yield (179.68%) (138.70%) (23.03%)

Profitability

Metric CURX LEXX Biotechnology median
Gross margin — 100.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (411.10%) (162.60%) (57.72%)
Return on assets (357.22%) (134.20%) (49.22%)
Return on invested capital (356.67%) (662.56%) 0.00%

Growth

Metric CURX LEXX Biotechnology median
Revenue growth (TTM) — 9.08% 5.64%
EPS growth (last fiscal year) (466.67%) (40.43%) —
Revenue growth, 5-year CAGR — 17.53% 8.40%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric CURX LEXX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 45.95 10.60 4.73
Net debt to EBITDA 1.20 0.17 0.96

Dividend

Metric CURX LEXX Biotechnology median
Dividend yield — — 2.10%
Payout ratio — 0.00 0.00

Size

Metric CURX LEXX Biotechnology median
Market cap 6.98m 7.10m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack